Literature DB >> 28376692

Neuroversion: using electroconvulsive therapy as a bridge to deep brain stimulation implantation.

Nolan R Williams1, Greg Sahlem2, Jaspreet Pannu1, Istvan Takacs3, Baron Short2, Gonzalo Revuelta4, Mark S George2,4.   

Abstract

Parkinson's disease (PD) is a movement disorder with significant neuropsychiatric comorbidities. Electroconvulsive therapy (ECT) is effective in treating these neuropsychiatric symptoms; however, clinicians are reluctant to use ECT in patients with deep brain stimulation (DBS) implantations for fear of damaging the device, as well as potential cognitive side effects. Right unilateral ultra-brief pulse (RUL UBP) ECT has a more favorable cognitive side-effect profile yet has never been reported in PD patients with DBS implants. We present a case series of three patients with a history of PD that all presented with psychiatric decompensation immediately prior to planned DBS surgery. All three patients had DBS electrode(s) in place at the time and an acute course of ECT was utilized in a novel method to "bridge" these individuals to neurosurgery. The patients all experienced symptom resolution (psychosis and/or depression and/or anxiety) without apparent cognitive side effects. This case series not only illustrates that right unilateral ultra-brief pulse can be utilized in patients with DBS electrodes but also illustrates that this intervention can be utilized as a neuromodulatory "bridge", where nonoperative surgical candidates with unstable psychiatric symptoms can be converted to operative candidates in a manner similar to electrical cardioversion.

Entities:  

Keywords:  Bridging; deep brain stimulation; electroconvulsive therapy; interventional psychiatry; neuroversion

Mesh:

Year:  2017        PMID: 28376692     DOI: 10.1080/13554794.2016.1276605

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  1 in total

1.  Suicide in Parkinson's disease.

Authors:  Melissa Deanna Shepard; Kate Perepezko; Martijn P G Broen; Jared Thomas Hinkle; Ankur Butala; Kelly A Mills; Julie Nanavati; Nicole Mercado Fischer; Paul Nestadt; Gregory Pontone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-01-19       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.